Chaozhi Wang

Title: Chaozhi Wang: Innovator in Crystalline Pyridone Compounds

Introduction

Chaozhi Wang is a notable inventor based in Dongguan, China. He has made significant contributions to the field of chemistry, particularly in the development of crystalline pyridone compounds. His work has implications for medical treatments, showcasing the intersection of innovation and healthcare.

Latest Patents

Chaozhi Wang holds a patent for a crystalline compound titled "1-(3-fluorophenyl)-5-methyl-2-(1H)pyridone." This patent details the preparation methods, compositions, and applications of this crystalline pyridone compound. The compound is characterized as a white needle crystal that contains no water or other crystallization solvents. Its unit cell belongs to the monoclinic system and has a space group of P2/n, with specific dimensions: a=3.8512(2), b=20.2535(12), c=12.1628(6) Å, β=92.850(5)°, and a crystal cell volume V=947.53(9) ų. This pyridone compound crystal possesses essential properties for preparing treatment compositions on a large scale. It is particularly useful for treating organ fibrosis in the liver, kidney, and lung, as well as for reducing skin scars.

Career Highlights

Chaozhi Wang is currently employed at Sunshine Lake Pharma Co., Ltd. His role at the company allows him to further his research and development efforts in pharmaceutical applications. His innovative work has positioned him as a key figure in the field of medicinal chemistry.

Collaborations

Chaozhi Wang has collaborated with notable colleagues, including Zhaolin Fu and Lijian Tao. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Chaozhi Wang's contributions to the field of crystalline pyridone compounds highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the pharmaceutical industry and offers promising solutions for various health conditions.